## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.5% below STRENGTH zone (3.0-6.0%); PEG 2.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($216.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. Verisk Analytics Inc. Stock Rallies 2.0%, Outperforms Peers**
- Source: 富途牛牛 | 20251230T080855 | Bullish | Relevance: 100%
- Verisk Analytics Inc. (VRSK) saw its stock rally by 2.0%, outperforming its peers. The article also provides a brief financial report for Unity Software (U.US), highlighting its fourth-quarter revenue of $609 million and a quarterly loss of 66 cents per share. Due to copyright issues, the full Dow Jones news content is temporarily unavailable.

**2. Verisk scraps $2.35B acquisition of roofing software maker AccuLynx**
- Source: SiliconANGLE | 20251230T010100 | Bearish | Relevance: 100%
- Verisk Analytics Inc. has canceled its $2.35 billion acquisition of AccuLynx, a roofing software company, due to delays in regulatory approval from the U.S. Federal Trade Commission. The FTC did not complete its review by the December 26 termination deadline, leading Verisk to scrap the deal. AccuLynx, however, considers the termination invalid, while Verisk plans to pay back the $1.5 billion debt it incurred for the acquisition.

**3. Verisk Analytics Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251229T163000 | Bullish | Relevance: 100%
- Verisk Analytics Inc. (VRSK) stock rose 2.00% to $224.74 on Monday, outperforming the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) which saw declines of 0.35% and 0.51% respectively. This marks the third consecutive day of gains for the company's stock, despite a grim overall trading session for the market.

**4. Verisk terminates $2.35bn agreement to purchase AccuLynx**
- Source: Insurance Insider US | 20251229T162316 | Somewhat-Bearish | Relevance: 100%
- Verisk has terminated its definitive agreement to purchase the software as a service platform AccuLynx. The data analytics provider had previously announced in July that it intended to acquire AccuLynx in an all-cash deal worth $2.35bn. The article does not provide reasons for the termination.

**5. Verisk Analytics Terminates Multiple Material Agreements**
- Source: TradingView — Track All Markets | 20251229T140911 | Somewhat-Bearish | Relevance: 100%
- Verisk Analytics (VRSK) announced the termination of two material agreements. The company ended its merger agreement with ExactLogix (AccuLynx.com) as the transaction was not completed by the outside date of December 26, 2025. Additionally, Verisk's $750 million senior unsecured delayed draw term loan facility automatically terminated on the same date.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 16.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Momentum building: MRS_10 improving +2.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.70 signals overvaluation risk, limited margin of safety. Forward P/E 29.2x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.3B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.70 |
| Forward P/E | 29.2 |
| Current P/E | 32.3 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.0% to 1.5% (+2.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (0.96), confirming momentum. RSI neutral at 57. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.52% (CS: 90) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.96 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 0.834x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $224.36
- **Stop Loss:** $216.64 (3.4% risk)
- **Target:** $232.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 170
- **Position Value:** $38,141.20
- **Portfolio %:** 38.14%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*